The U.S. Department of Health and Human Services (HHS) is awarding the pharmaceutical company Moderna $590 million to ...
Atara Biotherapeutics said on Tuesday the U.S. health regulator has placed a clinical hold on its trials for cancer cell therapies, sending the drug developer's shares down more than 4% in premarket ...
Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI) today announces that half of the patients in the ongoing Phase III study for the drug candidate AKP02G2 ...
The design for a medical study in 1743 that was never carried out may have inspired James Lind’s groundbreaking clinical ...
MyChesCo on MSN3d
Breakthrough in Cancer Treatment? Context Therapeutics Launches Phase 1 Trial for CLDN6-Targeted TherapyCNTX has announced that the first patient has been dosed in its Phase 1 clinical trial evaluating CTIM-76. This experimental ...
A breakthrough study highlights Xenon gas as a potential game-changer in treating Alzheimer’s disease, demonstrating its ...
Most treatments being pursued today to protect against Alzheimer's disease focus on amyloid plaques and tau tangles that accumulate in the brain, but new research points to a novel -- and noble -- ...
Most treatments being pursued today to protect against Alzheimer's disease focus on amyloid plaques and tau tangles that ...
CTI Clinical Trial & Consulting Services (CTI), a global, privately held, full-service research organization, headquartered ...
Study finding Xenon gas could protect against Alzheimer’s disease leads to start of clinical trial
Most treatments being pursued today to protect against Alzheimer’s disease focus on amyloid plaques and tau tangles that accumulate in the brain, but new research from Mass General Brigham and ...
Illumina will offer its DRAGEN analysis software on Nvidia’s accelerated computing platforms through the next-gen sequencing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback